Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 44Breast Neoplasms 42Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 21Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Ovarian Neoplasms 11Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Pancreatic Neoplasms 10Melanoma 10Brain Neoplasms 9Sarcoma 7Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Multiple Myeloma 6Gastrointestinal Neoplasms 6Disease 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bronchitis, Chronic × Blood Specimen Collection × 1 year × Clear all
NCT06122077 2025-08-05

PROACT-LUNG

Freenome Holdings Inc.

Recruiting
20,000 enrolled
Thoracic

Emphysema, Lung Neoplasms, Respiratory Distress Syndrome, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡